Wolverine Trading’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $686K | Buy |
+10,700
| New | +$522K | ﹤0.01% | 3321 |
|
|
2025
Q2 | – | Sell |
-6,600
| Closed | -$206K | – | 5158 |
|
|
2025
Q1 | $206K | Sell |
6,600
-3,500
| -35% | -$115K | ﹤0.01% | 3932 |
|
|
2024
Q4 | $353K | Sell |
10,100
-11,200
| -53% | -$419K | ﹤0.01% | 3837 |
|
|
2024
Q3 | $870K | Buy |
21,300
+1,300
| +7% | +$60.5K | ﹤0.01% | 2497 |
|
|
2024
Q2 | $953K | Buy |
20,000
+900
| +5% | +$36.9K | ﹤0.01% | 2224 |
|
|
2024
Q1 | $828K | Buy |
19,100
+5,300
| +38% | +$253K | ﹤0.01% | 2368 |
|
|
2023
Q4 | $698K | Buy |
13,800
+9,000
| +188% | +$431K | ﹤0.01% | 2618 |
|
|
2023
Q3 | $218K | Buy |
+4,800
| New | +$198K | ﹤0.01% | 3653 |
|
|
2022
Q1 | – | Sell |
-110,800
| Closed | -$3.38M | – | 5883 |
|
|
2021
Q4 | $3.38M | Buy |
110,800
+3,600
| +3% | +$113K | ﹤0.01% | 1420 |
|
|
2021
Q3 | $3.6M | Sell |
107,200
-3,800
| -3% | -$143K | ﹤0.01% | 1563 |
|
|
2021
Q2 | $4.39M | Sell |
111,000
-8,200
| -7% | -$321K | 0.01% | 1264 |
|
|
2021
Q1 | $5.33M | Buy |
119,200
+91,800
| +335% | +$5.12M | 0.01% | 1061 |
|
|
2020
Q4 | $1.57M | Sell |
27,400
-181,900
| -87% | -$9.06M | ﹤0.01% | 1934 |
|
|
2020
Q3 | $10.1M | Buy |
209,300
+101,400
| +94% | +$5.63M | 0.02% | 528 |
|
|
2020
Q2 | $6.41M | Sell |
107,900
-5,500
| -5% | -$306K | 0.02% | 684 |
|
|
2020
Q1 | $5.47M | Sell |
113,400
-64,000
| -36% | -$3.57M | 0.02% | 721 |
|
|
2019
Q4 | $10.7M | Sell |
177,400
-33,200
| -16% | -$1.98M | 0.03% | 648 |
|
|
2019
Q3 | $12.4M | Buy |
210,600
+89,400
| +74% | +$5.83M | 0.04% | 442 |
|
|
2019
Q2 | $7.79M | Sell |
121,200
-17,300
| -12% | -$1.22M | 0.02% | 656 |
|
|
2019
Q1 | $11.2M | Buy |
138,500
+8,100
| +6% | +$523K | 0.03% | 449 |
|
|
2018
Q4 | $6.7M | Sell |
130,400
-7,700
| -6% | -$393K | 0.02% | 640 |
|
|
2018
Q3 | $7.12M | Buy |
138,100
+72,600
| +111% | +$3.41M | 0.02% | 749 |
|
|
2018
Q2 | $2.89M | Hold |
65,500
| – | – | 0.01% | 1273 |
|
|
2018
Q1 | $2.89M | Buy |
65,500
+11,100
| +20% | +$564K | 0.01% | 1273 |
|
|
2017
Q4 | $2.74M | Sell |
54,400
-4,200
| -7% | -$230K | 0.01% | 1287 |
|
|
2017
Q3 | $2.97M | Buy |
58,600
+16,700
| +40% | +$875K | 0.01% | 1078 |
|
|
2017
Q2 | $2.17M | Sell |
41,900
-38,300
| -48% | -$1.78M | 0.01% | 1191 |
|
|
2017
Q1 | $3.24M | Buy |
80,200
+14,200
| +22% | +$638K | 0.02% | 885 |
|
|
2016
Q4 | $3.16M | Sell |
66,000
-7,200
| -10% | -$285K | 0.02% | 1030 |
|
|
2016
Q3 | $2.6M | Sell |
73,200
-11,000
| -13% | -$344K | 0.01% | 1138 |
|
|
2016
Q2 | $1.95M | Buy |
+84,200
| New | +$2.72M | 0.01% | 1122 |
|
Other funds holding IONS
BG
DTC
Wolverine Trading's IONS Position: Q3 2025 in Review
Wolverine Trading opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2025: 27,585 shares worth $1.77M. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IONS as recently as Q4 2024.
Wolverine Trading first reported a position in IONS in Q2 2016 and has held it in 29 quarters since. The position peaked at $9.72M in Q3 2020. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.
- Wolverine Trading held 27,585 shares of Ionis Pharmaceuticals worth $1.77M as of Q3 2025.
- Ionis Pharmaceuticals was a new Wolverine Trading position in Q3 2025.
- Ionis Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2297 holding.
- Wolverine Trading first reported a position in Ionis Pharmaceuticals in Q2 2016 and has held it in 29 quarters since.
- Wolverine Trading's Ionis Pharmaceuticals position peaked at $9.72M in Q3 2020.
- 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.